TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
0.6981
+0.0112 (1.63%)
Jan 22, 2026, 3:01 PM EST - Market open
TuHURA Biosciences Employees
TuHURA Biosciences had 19 employees as of December 31, 2024. The number of employees increased by 18 or 1,800.00% compared to the previous year.
Employees
19
Change (1Y)
18
Growth (1Y)
1,800.00%
Revenue / Employee
n/a
Profits / Employee
-$1,541,833
Market Cap
42.39M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 19 | 18 | 1,800.00% |
| Dec 31, 2023 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HURA News
- 5 weeks ago - TuHURA Biosciences Announces its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone - PRNewsWire
- 6 weeks ago - TuHURA Biosciences Provides Corporate Update Following Recent Financing - PRNewsWire
- 6 weeks ago - TuHURA Biosciences, Inc. Announces $15.6 Million Registered Direct Offering - PRNewsWire
- 6 weeks ago - TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor (DOR) as a New Target in Overcoming Acquired Resistance to Immune Checkpoint Inhibitors at the 57th ASH Annual Meeting and Exposition - PRNewsWire
- 2 months ago - TuHURA Biosciences, Inc. Reports Third Quarter 2025 Financial Results and Provides a Corporate Update - PRNewsWire
- 2 months ago - TuHURA Biosciences Discovery Research on Targeting the Delta Opioid Receptor (DOR) to Reprogram Myeloid-Derived Suppressor Cells (MDSCs) Selected for Oral Presentation at the 67th ASH Annual Meeting and Exposition - PRNewsWire
- 5 months ago - TuHURA Biosciences, Inc. to Present at the 27th Annual H.C. Wainwright Global Investment Conference - PRNewsWire
- 5 months ago - TuHURA Biosciences, Inc. Reports Second Quarter 2025 Financial Results and Provides a Corporate Update - PRNewsWire